Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Locally Advanced Breast Cancer × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Polycystic Ovary Syndrome 5 Neoplasm Metastasis 2 Leiomyoma 2 Infertility 2 is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1 Ovarian Cysts 1 Locally Advanced Breast Cancer 1 Infertility, Female 1 Breast Carcinoma In Situ 1 Anovulation 1 Abortion, Spontaneous 1

Interventions

Neoadjuvant Therapy 1 Letrozole 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05809024 2023-04-12

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Shandong Cancer Hospital and Institute

Phase 4 Recruiting

Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡